Founding team

Václav Navrátil –  CEO & CTO

Václav is the main inventor of the DIANA technology and the CEO of our new company. He also still directly leads our research and developmental activities.
Václav studied biochemistry and theoretical chemistry at the Charles University in Prague and subsequently worked as a research scientist at the IOCB Prague.

Martin Dienstbier – CFO & COO

Martin facilitated our transformation from an academic project into a business venture. He is now responsible for finances & operations. 
Martin studied molecular biology at the University of Cambridge and then worked as a research fellow at the University of Oxford, followed by a career in management consulting with the Boston Consulting Group.  

Jiří Schimer – Head of chemistry

Jiří is our chemistry guru who is responsible for designing and synthesizing small-molecular probes against new protein targets, which is the core of the DIANA technology.
Jiří studied biochemistry at the Charles University in Prague. He then worked as a postdoctoral fellow at Georgia Institute of Technology and at IOCB Prague.

Tyky

Jan Tykvart – Head of diagnostics

Jan serves both as a Head of our diagnostics unit and Head of laboratory operations. He is also instrumental in developing our new R&D projects. 
Jan studied biochemistry at the Charles University in Prague, followed by PhD at IOCB. He then worked as a postdoctoral fellow at the University of Toronto, where he gained experience in developing diagnostic kits.

 

DSC_1431-1

Jitka Zemanová Research scientist

Jitka contributes to the development of our diagnostic applications and runs our HTS screening projects. 
Jitka studied biochemistry at the Masaryk University in Brno and worked as a junior researcher at IOCB, where she facilitated the   development of different applications of the DIANA technology.

 

Jakub Hejdanek

Jakub Hejdánek –  Research scientist

Jakub works on the development of DIANA-based ADME tests and is also supporting our various R&D activities. 
Jakub studied biophysical chemistry at the Charles University in Prague and subsequently worked as a junior researcher at IOCB, where he participated on the development of the DIANA technology.

Supervisory board

Jan Konvalinka (IOCB)
Co-inventor
IOCB representative

Jaromír Zahrádka (I&I Prague)
Technology transfer
IOCB representative

Pavel Brůžek (BTCZ Ventures)
Chairman of the board
Investor representative 

Miroslav Tvrzník (BPD Partners)
Investor representative

Contacts

DIANA Biotechnologies s.r.o.
Nad Safinou II 366
252 50 Vestec
Czech Republic